NCT07046195View on ClinicalTrials.gov

Optimal Combination of Adjuvant Radiotherapy and Immunotherapy for Breast Cancer

Active, not recruitingOBSERVATIONAL
Enrollment

250

Participants

Timeline

Start Date

December 11, 2024

Primary Completion Date

July 31, 2027

Study Completion Date

July 31, 2028

Conditions
Hypofractionated RadiotherapyTriple Negative Breast Cancer (TNBC)Immunotherapy
Trial Locations (1)

51000

Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou

All Listed Sponsors
lead

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

OTHER

NCT07046195 - Optimal Combination of Adjuvant Radiotherapy and Immunotherapy for Breast Cancer | Biotech Hunter | Biotech Hunter